TNK1 Research (IMAGE)
Caption
Ph.D. graduate, Dr. Tsz-Yin Chan, who studied TNK1 alongside BYU professor Dr. Josh Andersen for the past six years, holds a vial of the newly created drug that is now ready for clinical trials.
Credit
Jaren Wilkey/BYU Photo
Usage Restrictions
N/A
License
Licensed content